Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in TBPH — Theravance Biopharma, Inc.

CIK 916542 Boston, MA
Back to TBPH Full portfolio

Position in TBPH

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$19,973,470
-$745,358 QoQ
Shares Held
1,174,910
-8.0% QoQ
Ownership
2.26%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#10
of 179 holders
Holding Since
Sep 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TBPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. TBPH ranks #7 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
This page 		1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in TBPH

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,973,470 1,174,910
2026-03-31 $20,718,828 1,276,576
2025-12-31 $21,815,092 1,165,959
2025-09-30 $15,904,962 1,089,381
2025-06-30 $3,404,431 308,652
2025-03-31 $1,559,124 174,594
2024-12-31 $1 143
2024-09-30 $558,630 69,309
2022-03-31 $79,128 8,277
2021-12-31 $60,321 5,459
2021-09-30 $364,834 49,302